← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2009Last known activity
Feb 28, 2026
Timeline
2000s
- Jul 1, 2004
Bellicum Pharmaceuticals— Founded
Drugs by trial phase (27 distinct, 27 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anemia
- Anemia, Aplastic
- Anemia, Diamond-Blackfan
- Anemia, Sickle Cell
- Disease
- Fanconi Anemia
- Graft vs Host Disease
- Hematologic Neoplasms
- Hemoglobinopathies
- Immune System Diseases
- Immunologic Deficiency Syndromes
- Immunoproliferative Disorders
- Leukemia
- Leukemia, Biphenotypic, Acute
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lymphatic Diseases
- Lymphohistiocytosis, Hemophagocytic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Melanoma
- Metabolic Diseases
- Multiple Myeloma
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasms
- Osteopetrosis
- Pancytopenia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Stomach Neoplasms
- Suicide
- Thalassemia
- Uveal Neoplasms
Recent trials (27)
- NCT03594162CollaboratorN/A—
- NCT03639844Lead sponsorN/A—
- NCT07164469CollaboratorPhase 2Feb 28, 2026
- NCT06347068CollaboratorPhase 1Jun 27, 2024
- NCT06096038CollaboratorPhase 1/Phase 2Dec 31, 2023
- NCT06066424CollaboratorPhase 1Oct 24, 2023
- NCT05620342CollaboratorEarly Phase 1Jan 15, 2023
- NCT04650451Lead sponsorPhase 1Dec 7, 2020
- NCT03807063CollaboratorPhase 1Jul 1, 2019
- NCT03696784CollaboratorPhase 1Mar 12, 2019
- NCT03699475Lead sponsorPhase 2/Phase 3Dec 27, 2018
- NCT03459170Lead sponsorPhase 1Feb 1, 2018
- NCT03056339CollaboratorPhase 1/Phase 2Jun 1, 2017
- NCT02487459Lead sponsorPhase 1May 1, 2017
- NCT02786485Lead sponsorPhase 1May 1, 2017
Details
- Founded
- Houston, TX, US Jul 1, 2004
- Last known activity
- Feb 28, 2026